Fueling the Engine
Prime Directive Labs Inc. raises equity capital to fund long-term R&D and operational growth.
Prime Directive Labs Inc.
The commercial R&D entity. We raise venture capital to build proprietary technology, secure IP, and develop the Sentinel infrastructure.
Prime Directive Foundation
The non-profit governance layer. It manages the AETERNOS token treasury and community grants. It does not accept equity investment.
Equity Investment
Long-Term Value
Focus on fundamental technology and IP generation, not short-term speculation.
Regulated Structure
Investment in a Canadian Corporation (Prime Directive Labs Inc.) with standard governance rights.
No Token Sales
We do not sell tokens to investors. AETERNOS is a governance utility, not a security.
Seed Round
Status: Early Access
Qualified institutional investors and accredited individuals may request access to our data room.
Request Data RoomThis page is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Any such offer will be made only pursuant to a definitive subscription agreement and confidential private placement memorandum.